G-NiiB M3CRC Non-Invasive Colorectal Cancer Risk Prediction Test 1pc
byG-NiiB
$2,389.00
1pc Item code 408179
- World's First "M3 Bacterial Gene Markers Test Technology", researched and developed by the Faculty of Medicine of A Renowned University in Hong Kong
- 3 risk prediction indices: detects colorecatal cancer, non-advanced adenoma and recurrent adenoma
- Non-invasive and painless stool collection, convenient and easy-to-use
- Reports & doctor consultation inclusive
- Dietary recommendations included
Origin
Hong KongProduct Description
G-NiiB M3CRC Non-Invasive Colorectal Cancer Risk Prediction Test, researched and developed by the Faculty of Medicine of A Renowned University in Hong Kong, provides 3 risk prediction including colon cancer, non-advanced adenoma and recurrent adenoma. The sensitivity of colon cancer detection is 94%^, which is comparable to colonoscopy. The risk of adenoma recurrence and less than 5mm non-advanced adenoma can be detected. The sensitivity of adenoma recurrence detection is 90%^. The prediction test only requires stool collection which is non-invasive and painless.
Contained in this box:
Stool collection tools
^ The Chinese University of Hong Kong. CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90% [Press Release]. 2021
Recently viewed products
Pay Securely
Quality eshop award
Follow Us On
